Dasotraline
Total Payments
$7.6M
Transactions
1,949
Doctors
9
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $32,370 | 44 | 5 |
| 2018 | $7.5M | 1,900 | 0 |
| 2017 | $17,540 | 5 | 4 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7.5M | 1,900 | 99.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,750 | 6 | 0.2% |
| Travel and Lodging | $16,573 | 16 | 0.2% |
| Consulting Fee | $14,790 | 4 | 0.2% |
| Food and Beverage | $797.02 | 23 | 0.0% |
Payments by Type
Research
$7.5M
1,900 transactions
General
$49,910
49 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Dasotraline Binge Eating Disorder Extension Study | Sunovion Pharmaceuticals Inc. | $3.5M | 0 |
| A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder | Sunovion Pharmaceuticals Inc. | $3.2M | 0 |
| SEP360-108 | Sunovion Pharmaceuticals Inc. | $608,833 | 0 |
| Dasotraline Pediatric Extension Study | Sunovion Pharmaceuticals Inc. | $153,704 | 0 |
| Dasotraline Pediatric ADHD Study | Sunovion Pharmaceuticals Inc. | $69,943 | 0 |
| Dasotraline Adult ADHD Study | Sunovion Pharmaceuticals Inc. | $53,822 | 0 |
Top Doctors Receiving Payments for Dasotraline
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Marietta, GA | $7.5M | 1,900 |
| , M.D | Internal Medicine | Jamica Plain, MA | $11,095 | 2 |
| , MD | Family Medicine | Au Train, MI | $6,550 | 8 |
| , MD | Endocrinology, Diabetes & Metabolism | Albuqeurque, NM | $6,520 | 10 |
| , MD | Internal Medicine | Surfside, FL | $6,470 | 10 |
| , M.D | Health Maintenance Organization | Laguna Beach, CA | $6,418 | 8 |
| , M.D | Family Medicine | Newport Beach, CA | $6,413 | 8 |
| , M.D | Psychiatry | New York, NY | $3,000 | 1 |
| , MD | Psychiatry | Boston, MA | $2,750 | 1 |
| Takuya Saito | Child & Adolescent Psychiatry | — | $694.61 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $7.6M
- Total Doctors 9
- Transactions 1,949
About Dasotraline
Dasotraline is a drug associated with $7.6M in payments to 9 healthcare providers, recorded across 1,949 transactions in the CMS Open Payments database. The primary manufacturer is Sunovion Pharmaceuticals Inc..
Payment data is available from 2017 to 2019. In 2019, $32,370 was paid across 44 transactions to 5 doctors.
The most common payment nature for Dasotraline is "Unspecified" ($7.5M, 99.3% of total).
Dasotraline is associated with 6 research studies, including "Dasotraline Binge Eating Disorder Extension Study" ($3.5M).